On August 26, 2019, General Secretary Xi Jinping presided over the fifth meeting of the Central Financial and Economic Affairs Commission, emphasizing the need to foster entrepreneurship and craftsmanship to cultivate a group of "Specialized and Innovative" SMEs. Following the "Guiding Opinions on Promoting the Development of 'Specialized and Innovative' SMEs in Beijing" (Jingjingxinfa [2019] No. 86), and after rigorous assessment by the Beijing Municipal Bureau of Economy and Information Technology, our company has been honored as one of the first batch of "Specialized and Innovative" SMEs in Beijing for 2020.
This successful selection signifies that Novel Medical is recognized by various government departments for its professionalism, innovation, economic benefits, and management capabilities. It highlights Novel Medical's position in the industry, representing cutting-edge innovation and mastery of key technologies in the field, with sustainable development capabilities.
Professionalism: Expert in nuclear safety and nuclear medicine.
Leveraging decades of Tsinghua University's medical physics research, the company has established a nuclear medicine molecular imaging research team. It is dedicated to nuclear security and nuclear medicine, expanding from nuclear imaging to radiology and radiotherapy, and integrating other technologies. The company aims to become a global supplier of medical diagnostics and nuclear radiation monitoring equipment, software, and services.
Refinement: Efficient and meticulous management system.
The company, adhering to the concept of continuous improvement, has established efficient and meticulous management systems and processes. It has received certifications such as ISO9001 for quality management, ISO13485 for medical devices, ISO14001 for environmental management, ISO14001-IQNET for environmental systems, and GB/T29490-2013 for intellectual property management. These standardized practices ensure the production of high-quality products.
Specialization: Unique products and high-quality services.
The company's radioactive intelligent monitoring system combines nuclear radiation monitoring with dynamic video technology, entering the intelligent video security field and providing strong technical support for national nuclear safety. Preclinical molecular imaging products can track the metabolism of drugs in animals in vivo non-invasively, verify their pathological properties and toxicity, increase drug development efficiency, shorten new drug development cycles, and reduce costs, thus accelerating the new drug development process. Clinical SPECT products promote standardized diagnostic procedures and precision medicine concepts in China, enhancing hospitals' overall clinical technical levels and service quality. Quality stems from expertise. Novel Medical has a well-trained technical support team, dedicated to providing high-quality service with the mission of "prompt acquisition, accurate response," and always putting users first.
Innovation: Leading the future with independent technological advancements
Since its establishment, the company has adhered to independent innovation, owning over 100 intellectual property rights and receiving numerous honors, including "National Intellectual Property Advantage Enterprise" and "Beijing Intellectual Property Demonstration Unit." With strong R&D capabilities, its products, such as the radioactive intelligent monitoring system, multimodal animal PET/SPECT/CT integrated machine, and clinical SPECT, are reliable and mature. Through independent innovation, the company provides integrated imaging technology solutions to global users, allowing everyone to benefit from advancements in nuclear technology.
Language
